Compositions and methods for succinate production

US9605285B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9605285-B2
Application numberUS-201213981517-A
CountryUS
Kind codeB2
Filing dateJan 25, 2012
Priority dateJan 25, 2011
Publication dateMar 28, 2017
Grant dateMar 28, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.

First claim

Opening claim text (preview).

What is claimed is: 1. A genetically modified yeast cell having an active succinate fermentation pathway from phosphoenolpyruvate or pyruvate to succinate, wherein the active succinate fermentation pathway comprises an exogenous malate dehydrogenase gene encoding a polypeptide comprising an amino acid sequence with at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:172. 2. The genetically modified yeast cell of claim 1 , wherein the active succinate fermentation pathway includes the reactions: (a) pyruvate to oxaloacetate; (b) oxaloacetate to malate; (c) malate to fumarate; and (d) fumarate to succinate. 3. The genetically modified yeast cell of claim 2 , wherein the active succinate fermentation pathway further includes: (e) export of succinate from inside the cell to the extracellular environment. 4. The genetically modified yeast cell of claim 3 , wherein the cell comprises one or more exogenous genes that encode an enzyme that catalyzes any of reactions (a) through (e). 5. The genetically modified yeast cell of claim 4 , wherein the cell comprises one or more copies of one or more exogenous genes selected from the group consisting of pyruvate carboxylase, fumarate reductase, and succinate exporter genes. 6. The genetically modified yeast cell of claim 5 , wherein said exogenous pyruvate carboxylase gene is derived from a fungal pyruvate carboxylase source gene and encodes a polypeptide with at least 95% sequence identity to a polypeptide encoded by the fungal pyruvate carboxylase source gene, wherein the fungal pyruvate carboxylase source gene is not derived from R. oryzae. 7. The genetically modified yeast cell of claim 5 , wherein said exogenous fumarase gene is derived from a yeast fumarase source gene and encodes a polypeptide with at least 95% sequence identity to a polypeptide encoded by the yeast fumarase source gene. 8. The genetically modified yeast cell of claim 7 , wherein said exogenous fumarase gene encodes a polypeptide comprising an amino acid sequence with at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NO:2. 9. The genetically modified yeast cell of claim 5 , wherein said exogenous fumarate reductase gene is derived from a protozoan fumarate reductase source gene and encodes a polypeptide with at least 95% sequence identity to a polypeptide encoded by the protozoan fumarate reductase source gene. 10. The genetically modified yeast cell of claim 9 , wherein said exogenous fumarate reductase gene encodes a polypeptide comprising an amino acid sequence with at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NO:174, SEQ ID NO:176, SEQ ID NO:178, or SEQ ID NO:180. 11. The genetically modified yeast cell of claim 2 , wherein the active succinate fermentation pathway comprises the reaction phosphoenolpyruvate to oxaloacetate in addition to reaction (a). 12. The genetically modified yeast cell of claim 11 , wherein the cell comprises one or more copies of one or more exogenous phosphoenolpyruvate carboxylase genes. 13. The genetically modified yeast cell of claim 2 , wherein the cell comprises a deletion or disruption of an endogenous malic enzyme gene. 14. The genetically modified yeast cell of claim 2 , wherein the cell comprises a deletion or disruption of an endogenous pyruvate decarboxylase gene. 15. The genetically modified yeast cell of claim 1 , wherein the yeast cell is from the Pichia fermentans/Issatchenkia orientalis clade. 16. A method of producing succinate comprising culturing the genetically modified yeast cell of claim 1 in the presence of at least one carbon source and isolating succinate from the culture. 17. The A-genetically modified yeast cell of claim 1 , wherein the yeast cell comprises the species Issatchenkia orientalis. 18. The genetically modified yeast cell of 15 , wherein the yeast cell is succinate resistant. 19. The genetically modified yeast cell of claim 15 , wherein the genetically modified yeast cell comprises one or more copies of an exogenous pyruvate carboxylase gene derived from a yeast pyruvate carboxylase source gene and encodes a polypeptide with at least 95% sequence identity to a polypeptide encoded by the yeast pyruvate carboxylase source gene. 20. The genetically modified yeast cell of claim 19 , wherein said exogenous pyruvate carboxylase gene encodes a polypeptide comprising an amino acid sequence with at least 95% sequence identity to the amino acid sequence set forth in SEQ ID NO:8, SEQ ID NO:10, or SEQ ID NO:12.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9605285B2 cover?
The present application provides genetically modified yeast cell comprising an active succinate fermentation pathway, as well as methods of using these cells to produce succinate.
Who is the assignee on this patent?
Finley Kenneth R, Huryta Jeanette M, Mastel Beth M, and 8 more
What technology area does this patent fall under?
Primary CPC classification C12N15/815. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).